Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.

Dave Coulier, 65, announced on Tuesday that he has stage 3 non-Hodgkin lymphoma. An oncologist explains the symptoms, ...

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

(Howard Dean, 11/13) Miami Herald: CDC Numbers Offer Good News On HIV Infections Overall But Reveal A Crisis For Latinos When the Centers for Disease Control and Prevention published data in May of ...

Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves ...

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...

Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

THE Capital Markets and Securities Authority (CMSA) has said that the establishment of more investment funds is part of the ...

But Dr. Joseph McGowan, HIV services medical director at Northwell Health, said he hadn’t seen a noticeable decline in STI ...

The free contraceptives will be accompanied by 45,500 educational pamphlets on HIV/AIDS, 3,000 pre- and post-exposure ...

expand integrated care and accelerate efforts to eliminate vertical transmission of HIV, Syphilis, and Hepatitis B, and increase ART coverage for children and adolescents to ensure equity of treatment ...